Abstract
Copeptin is a stable, sensitive surrogate marker for Arginine vasopressin (AVP) [1]. It has been shown to be useful as a prognostic marker in patients with acute diseases [2]. Preoperative B-type natriuretic peptides is a predictor of mortality and myocardial infarction in patients undergoing noncardiac surgery [3]. The aim of the study was to evaluate the serum concentrations of copeptin, and B-type natriuretic peptide (BNP), and 3-years mortality in a cohort of patients operated for carotid stenosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
